Literature DB >> 9282839

Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.

D P Hartley1, D J Kroll, D R Petersen.   

Abstract

Toxicity associated with prooxidant-mediated hepatic lipid peroxidation is postulated to originate from the interaction of the aldehydic end products of lipid peroxidation with cellular constituents. The principal alpha,beta-unsaturated aldehydic products of lipid peroxidation, 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA), are known to modify proteins through covalent alkylation of lysine, histidine, and cysteine amino acid residues. To detect and characterize the formation of 4-HNE- and MDA-adducted proteins during prooxidant-initiated lipid peroxidation, rabbit polyclonal antibodies were raised to 4-HNE-sulfhydryl, dinitrophenylhydrazine (DNPH)-4-HNE-sulfhydryl, and MDA-amine conjugates of keyhole limpet hemocyanin (KLH). Each antiserum displayed high antibody titers to either 4-HNE-metallothionein, DNPH-albumin, or MDA-albumin adducts when measured by ELISA. To study the formation of 4-HNE- and MDA-protein adducts during prooxidant-initiated cellular injury, isolated hepatocytes were exposed to either carbon tetrachloride or iron/ascorbate for 2 h. Indices of hepatocellular oxidative stress (i.e., cell viability and glutathione status) and lipid peroxidation (i.e., formation of 4-HNE, protein carbonyls, and MDA) were monitored continuously. Hepatocellular viability was affected moderately by carbon tetrachloride, while cellular reduced glutathione status was moderately affected by both iron/ascorbate and carbon tetrachloride. Levels of MDA and protein carbonyls increased dramatically with both prooxidants, whereas 4-HNE levels did not change significantly over the time course studied. In addition, hepatocellular proteins were immunoprecipitated with each antiserum, and aldehyde-modified immunopositive proteins were detected by immunoblotting. Prooxidant-induced increases in MDA corresponded with increases in intensity and number of MDA-adducted proteins over the time course studied. A total of 13 MDA-modified proteins (20, 25, 28, 30, 33, 38, 41, 45, 80, 82, 85, 130, and 150 kDa) were detected with the MDA-amine antiserum. Additionally, both iron/ascorbate- and carbon tetrachloride-induced formation of DNPH-derivatizable protein carbonyls corresponded quantitatively with the ability to detect specific proteins (80, 100, 130, and 150 kDa) with the DNPH-4-HNE-cysteine antiserum. Neither CCl4 nor iron/ascorbate elicited changes in 4-HNE or induced the formation of 4-HNE-modified proteins when assessed by immunoprecipitation-immunoblot analysis with the 4-HNE-sulfhydryl antiserum. In all instances detection of aldehyde-modified proteins was not associated with cell death and may be related to the function of these proteins as aldehyde-binding proteins which sequester electrophilic molecules during oxidative liver injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282839     DOI: 10.1021/tx960181b

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  23 in total

1.  Posttranslational modification and regulation of glutamate-cysteine ligase by the α,β-unsaturated aldehyde 4-hydroxy-2-nonenal.

Authors:  Donald S Backos; Kristofer S Fritz; James R Roede; Dennis R Petersen; Christopher C Franklin
Journal:  Free Radic Biol Med       Date:  2010-10-21       Impact factor: 7.376

Review 2.  Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?

Authors:  Jennalynn Styskal; Holly Van Remmen; Arlan Richardson; Adam B Salmon
Journal:  Free Radic Biol Med       Date:  2011-10-20       Impact factor: 7.376

Review 3.  Features and regulation of non-enzymatic post-translational modifications.

Authors:  Robert Harmel; Dorothea Fiedler
Journal:  Nat Chem Biol       Date:  2018-02-14       Impact factor: 15.040

Review 4.  Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease.

Authors:  Rebecca L Smathers; James J Galligan; Benjamin J Stewart; Dennis R Petersen
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

5.  The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).

Authors:  Jeffrey D Coleman; K Sandeep Prabhu; Jerry T Thompson; P Sreenivasula Reddy; Jeffrey M Peters; Blake R Peterson; C Channa Reddy; John P Vanden Heuvel
Journal:  Free Radic Biol Med       Date:  2007-01-08       Impact factor: 7.376

Review 6.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

7.  Stereochemical configuration of 4-hydroxy-2-nonenal-cysteine adducts and their stereoselective formation in a redox-regulated protein.

Authors:  Chika Wakita; Takuya Maeshima; Atsushi Yamazaki; Takahiro Shibata; Sohei Ito; Mitsugu Akagawa; Makoto Ojika; Junji Yodoi; Koji Uchida
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

8.  Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice.

Authors:  Arttatrana Pal; Neera Tewari-Singh; Mallikarjuna Gu; Chapla Agarwal; Jie Huang; Brian J Day; Carl W White; Rajesh Agarwal
Journal:  Free Radic Biol Med       Date:  2009-09-15       Impact factor: 7.376

9.  Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives.

Authors:  Andrew Vila; Keri A Tallman; Aaron T Jacobs; Daniel C Liebler; Ned A Porter; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2008-01-31       Impact factor: 3.739

10.  Effect of vitamin E on oxidative stress status in small intestine of diabetic rat.

Authors:  A Shirpoor; M-H-Khadem Ansari; S Salami; F-Ghaderi Pakdel; Y Rasmi
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.